-
2025-524646-94-00
Obstetrics – Preeclampsia 11
-
2024-517010-15-01
Post-operative recovery after hip fracture surgery in f 3
-
2024-517514-15-00
Mitochondrial encephalomyopathy, lactic acidosis, and s 4
-
2025-522491-89-00
Cardiovascular Disease 4
-
2024-517531-40-00
Phase I trial, healthy volunteers 1
-
2025-522498-12-00
iron deficiency in adolescent girls 6
-
2025-524725-41-00
Acute Myeloblastic Leukemia 3
-
2023-506030-70-00
Gastrointestinal cancers (including hepatocellular carc 10
-
2025-524728-22-01
Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) 9
-
2023-509659-15-00
Patients with ovarian cancer, fallopian tube cancer, pe 6
-
2023-508664-30-00
Acute kidney injury 5
-
2024-517082-16-01
Post medical abortion contraception 5
-
2025-523949-10-00
Healthy volunteers trial 3
-
2024-519644-33-00
oligozoospermia 4
-
2024-516257-44-00
Multiple myeloma 4
-
2025-522435-33-00
Hemophilia A 5 2026-06-17
-
2025-521327-67-00
Metastatic Castration-Resistant Prostate Cancer 4 2026-04-13
-
2024-512436-29-00
CARDIOVASCULAR DISEASES 11 2026-03-27
-
2025-521305-40-00
Participants with Advanced Solid Tumors 1 2025-07-22
-
2025-521375-31-00
Anesthesia and Analgesia, Patient safety 6 2025-06-17
-
2025-521373-13-00
anesthesia and analgesia patint safety 6 2025-06-15
-
2024-511477-29-00
Patients diagnosed with unresectable and / or metastati 4 2024-11-08
-
2024-515545-41-00
a prospective, case-controlled study 6 2024-09-05
-
2023-505804-42-00
NON SEGMENTAL VITILIGO 5 2024-07-10